Cargando…
Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems
The efficacy of antimitotics is limited by slippage, whereby treated cells arrested in mitosis exit mitosis without cell division and, eventually, escape apoptosis, constituting a serious resistance mechanism to antimitotics. Strategies to overcome slippage should potentiate the cancer cell killing...
Autores principales: | Pinto, Bárbara, Novais, Pedro, Henriques, Ana C., Carvalho-Tavares, Juliana, Silva, Patrícia M. A., Bousbaa, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229367/ https://www.ncbi.nlm.nih.gov/pubmed/35745782 http://dx.doi.org/10.3390/pharmaceutics14061209 |
Ejemplares similares
-
Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic
por: Henriques, Ana C., et al.
Publicado: (2021) -
The Role of Navitoclax in Myelofibrosis
por: Pandravada, Sasirekha, et al.
Publicado: (2021) -
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
por: Pinto, Bárbara, et al.
Publicado: (2020) -
Second-Generation Antimitotics in Cancer Clinical Trials
por: Novais, Pedro, et al.
Publicado: (2021) -
BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity
por: Novais, Pedro, et al.
Publicado: (2021)